Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Silcocks

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Epidemiologic Perspectives & Innovations : EP+I|September 28, 2005
An easy approach to the Robins-Breslow-Greenland variance estimatorPaul Silcocks
Trials|May 18, 2010
Spatial effects should be allowed for in primary care and other community-based cluster RCTSPaul Silcocks, Denise Kendrick
European Journal of Cancer (Oxford, England : 1990)|August 7, 2009
Correcting population-based survival for DCOs - why a simple method works and when to avoid itPaul Silcocks, Catherine S Thomson
European Heart Journal|March 17, 2005
Using BNP to develop a risk score for heart failure in primary careDavid Adlam, Paul Silcocks, Nigel Sparrow
Trials|June 18, 2010
P3MC: a double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in childrenPaul Silcocks, Diane Whitham, William Patrick Whitehouse
Oral Oncology|December 28, 2016
Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis)Richard Shaw, Binyam Tesfaye, Matt Bickerstaff, et al.
The Journal of Trauma|March 24, 2011
Validation of the IMPACT outcome prediction score using the Nottingham Head Injury Register datasetPaddy Yeoman, Hina Pattani, Paul Silcocks, et al.
Neurosurgery|January 18, 2007
Risk of malignancy after gamma knife stereotactic radiosurgeryJeremy Rowe, Alison Grainger, Lee Walton, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2010
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancerPaul Maddison, Alison Thorpe, Paul Silcocks, et al.
Future Oncology (London, England)|December 26, 2013
Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs FundRamya Ramaswami, Sean M O'Cathail, James H Brindley, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Epidemiologic Perspectives & Innovations : EP+I|September 28, 2005
An easy approach to the Robins-Breslow-Greenland variance estimatorPaul Silcocks
Trials|May 18, 2010
Spatial effects should be allowed for in primary care and other community-based cluster RCTSPaul Silcocks, Denise Kendrick
European Journal of Cancer (Oxford, England : 1990)|August 7, 2009
Correcting population-based survival for DCOs - why a simple method works and when to avoid itPaul Silcocks, Catherine S Thomson
European Heart Journal|March 17, 2005
Using BNP to develop a risk score for heart failure in primary careDavid Adlam, Paul Silcocks, Nigel Sparrow
Trials|June 18, 2010
P3MC: a double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in childrenPaul Silcocks, Diane Whitham, William Patrick Whitehouse
Oral Oncology|December 28, 2016
Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis)Richard Shaw, Binyam Tesfaye, Matt Bickerstaff, et al.
The Journal of Trauma|March 24, 2011
Validation of the IMPACT outcome prediction score using the Nottingham Head Injury Register datasetPaddy Yeoman, Hina Pattani, Paul Silcocks, et al.
Neurosurgery|January 18, 2007
Risk of malignancy after gamma knife stereotactic radiosurgeryJeremy Rowe, Alison Grainger, Lee Walton, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2010
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancerPaul Maddison, Alison Thorpe, Paul Silcocks, et al.
Future Oncology (London, England)|December 26, 2013
Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs FundRamya Ramaswami, Sean M O'Cathail, James H Brindley, et al.
Pageof 2